Infliximab as a steroid-sparing agent in refractory cutaneous sarcoidosis: Single-center retrospective study of 9 patients

Journal of the American Academy of Dermatology

Volumn 66, Issue 2, 2012, Pages 328-332

  Sené, Thomas ^a   Juillard, Caroline ^a   Rybojad, Michel ^a   Cordoliani, Florence ^a   Lebbé, Céleste ^a   Morel, Patrice ^a   Tazi, Abdellatif ^a   Guibal, Fabien ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; HYDROCORTISONE; HYDROXYCHLOROQUINE; INFLIXIMAB; METHOTREXATE; PREDNISONE;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; CLINICAL ARTICLE; CUTANEOUS SARCOIDOSIS; DISEASE COURSE; DRUG DOSE ESCALATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; LETTER; LONG TERM CARE; MALE; MEDICAL RECORD REVIEW; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; RELAPSE; RETROSPECTIVE STUDY; SARCOIDOSIS; TREATMENT RESPONSE;

EID: 84855859222     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2011.05.040     Document Type: Article

References (5)

1. M.C. Iannuzzi, B.A. Rybicki, and A.S. Teirstein Sarcoidosis N Engl J Med 357 2007 2153 2165
2. C. Badgwell, and T. Rosen Cutaneous sarcoidosis therapy updated J Am Acad Dermatol 56 2007 69 83 (Pubitemid 46001778)
3. R.P. Baughman, E.E. Lower, and M. Drent Inhibitors of tumor necrosis factor (TNF) in sarcoidosis: who, what, and how to use them Sarcoidosis Vasc Diffuse Lung Dis 25 2008 76 89
4. G.W. Hunninghake, U. Costabel, M. Ando, R. Baughman, J.F. Cordier, and R. du Bois ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders Sarcoidosis Vasc Diffuse Lung Dis 16 1999 149 173
5. A.M. Thielen, C. Barde, J.H. Saurat, and E. Laffitte Refractory chronic cutaneous sarcoidosis responsive to dose escalation of TNF-alpha antagonists Dermatology 219 2009 59 62